The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 17, 2023
Filed:
Jun. 21, 2021
Applicant:
Corcept Therapeutics Incorporated, Menlo Park, CA (US);
Inventors:
Hazel Hunt, Storrington, GB;
Lorna Duffy, Nottingham, GB;
Ian Strutt, Nottingham, GB;
Morgan Jouanneau, Nottingham, GB;
Thomas Hornsby, Nottingham, GB;
Mark Mills, Nottingham, GB;
Andrew William Phillips, Nottingham, GB;
Jon-Paul Ward, Nottingham, GB;
Assignee:
Corcept Therapeutics Incorporated, Menlo Park, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/14 (2006.01); C07D 403/04 (2006.01); C07D 403/12 (2006.01); C07D 403/14 (2006.01); C07D 231/56 (2006.01); C07D 409/14 (2006.01); C07D 413/14 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
C07D 401/14 (2013.01); C07D 231/56 (2013.01); C07D 403/04 (2013.01); C07D 403/12 (2013.01); C07D 403/14 (2013.01); C07D 409/14 (2013.01); C07D 413/14 (2013.01); C07D 487/04 (2013.01);
Abstract
The present disclosure provides compounds of Formula I or II. Compounds of Formula I or II may be used in pharmaceutical formulations, and may be used for modulating glucocorticoid receptors.